Zyomyx Inc.
Industry
- Medical Devices
- Pharmaceuticals
- Vaccines
See more in Biomedtracker
Latest on Zyomyx Inc.
Scrip
• By Vikas Dandekar
MUMBAI – Mylan NV President Rajiv Malik is in a sweet spot. The $6.8 billion Pittsburgh-headquartered generics drug maker is nearing windfall gains arising from a few hard-pursued programs. For on
Scrip
IN VITRO DIAGNOSTICS GeneCentric Diagnostics Inc. GeneCentric raises $5mm through Series A round Molecular diagnostics firm GeneCentric Diagnostics Inc. has raised $5mm from four undisclosed i
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions Metamark Genetics Inc. Endo Health Solutions Inc. HealthTronics Inc. HealthTronics Laboratory Solutions Endo International PLC (branded and generic drug